✦ LIBER ✦

Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer

✍ Scribed by Elisabeth D. Coene; Vera Schelfhout; Rosita A. Winkler; Anne-Marie Schelfhout; N. Van Roy; Madeleine Grooteclaes; F. Speleman; C. R. De Potter

Publisher: Springer
Year: 1997
Tongue: English
Weight: 557 KB
Volume: 430
Category: Article
ISSN: 1432-2307
DOI: 10.1007/s004280050045

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

c-erbB2 oncoprotein expression, gene amp

c-erbB2 oncoprotein expression, gene amplification, and chromosome 17 aneusomy in apocrine adenosis of the breast

✍ Selim, Abdel-Ghani A.; El-Ayat, Ghada; Wells, Clive A. 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

Ampli®cation of the c-erbB2 oncogene and numerical aberrations of chromosome 17 occur in human breast carcinomas. Apocrine adenosis (AA) of the breast has been shown occasionally to have c-erbB2 overexpression and a possible premalignant potential, but little is known about cellular level genetic al

Concomitant gastrin and ERBB2 gene ampli

Concomitant gastrin and ERBB2 gene amplifications at 17q12–q21 in the intestinal type of gastric cancer

✍ Virve Vidgren; Asta Varis; Arto Kokkola; Outi Monni; Pauli Puolakkainen; Stig No 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 177 KB 👁 1 views

Our recent studies using comparative genomic hybridization showed that gain or amplification at the 17q12-q21 region is very common in the intestinal type of gastric cancer. Here, we describe a fluorescence in situ hybridization study with gastrin (GAS)-specific and ERBB2-specific probes on ten spec

int-2 Amplification in breast cancer: As

int-2 Amplification in breast cancer: Association with decreased survival and relationship to amplification of c-erbb-2 and c-myc

✍ J. A. Henry; C. Hennessy; D. L. Leveit; T. W. J. Len Nard; B. R. Westley; F. E. 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 778 KB

Amplification of the int-2 oncogene was measured in a series of breast tumours and related to amplification of the c-myc and c-erbB-2 oncogenes, histopathological features and relapse-free and overall survival. int-2 was amplified in I I%, c-myc in 20% and c-erbB-2 in 27% of the tumours assessed. in

Overexpression of the c-erbB-2 protein i

Overexpression of the c-erbB-2 protein in human breast tumor cell lines

✍ Nancy E. Hynes; Heinz A. Gerber; Suzanne Saurer; Bernd Groner 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 1 views

The c-erbB-2 proto-oncogene is amplified in a high percentage of primary human breast tumors, suggesting that the overexpression of this gene may be involved in the development of human breast cancer. We have investigated five human breast tumor cell lines and have detected amplified c-erbB-2 gene c

Loss of heterozygosity at chromosome 17p

Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer

✍ Evgeny N. Imyanitov; Oleg I. Chernitsa; Irina F. Nikiforova 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 French ⚖ 703 KB

## Abstract Sixty DNA samples from breast carcinoma (BC) patients were analyzed by Southern blot to examine certain oncogene and anti‐oncogene alterations. Amplification of the HER‐2 oncogene was detected in 15 tumours (25%), c‐myc in 2 (3%) only and HER‐1 in none. Distribution of Hras‐1 oncogene a

Host immunosurveillance contributes to t

Host immunosurveillance contributes to the control of erbB-2 overexpression in HLA-A2-breast-cancer patients

✍ Paola Nisticò; Marcella Mottolese; Simona Cascioli; Maria Benevolo; Duilia Del B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 324 KB 👁 2 views

Overexpression of gp185 erbB-2 has been associated with reduced survival in breast-cancer patients. Our earlier results, now confirmed in a larger cohort of patients ( ), evidenced that the HLA-A2 allele may participate in the modulation of the erbB-2 tumor phenotype in vivo. In the present study, w